ERK1/2 is reported to be essential for MLCK expression and activity in vascular smooth muscle cells and breast cancer cells [47], [49], [50], [51]; while in astrocytes, P38 but not ERK1/2 or JNK upregulates the expression of MLCK [52]. Here, MYLK is linked to breast carcinoma.